How has been the historical performance of Prism Medico?

Answer:The historical performance of Prism Medico shows a significant increase in net sales over the years, rising from 5.28 Cr in March 2017 to 54.73 Cr in March 2019. Total operating income mirrored this trend, reaching 54.73 Cr in March 2019, up from 22.80 Cr in March 2018 and 5.28 Cr in March 2017. However, the company faced challenges with profitability, as it reported a profit before tax of -0.10 Cr in March 2019, following a profit of 0.07 Cr in March 2018 and a loss of -0.21 Cr in March 2017. Despite these challenges, the profit after tax turned positive in March 2019 at 0.04 Cr, compared to a negligible profit in March 2018 and a loss of -0.22 Cr in March 2017. The earnings per share (EPS) improved to 0.07 in March 2019 from -0.01 in March 2018 and -0.36 in March 2017.

In terms of assets and liabilities, total assets increased from 17.26 Cr in March 2017 to 21.13 Cr in March 2019, while total liabilities also rose from 17.26 Cr to 21.13 Cr during the same period. The company maintained a stable share capital of 6.06 Cr over the years, with total reserves increasing to 6.85 Cr in March 2019 from 6.81 Cr in the previous two years. Cash flow results indicate no cash inflow or outflow from operating, investing, or financing activities during the reported years, with closing cash and cash equivalents at 0.00 Cr in March 2019, March 2018, and March 2017. Overall, while Prism Medico has shown growth in sales and a turnaround in profit after tax, it continues to grapple with profitability and cash flow challenges.

Breakdown:
Prism Medico's financial performance from March 2016 to March 2019 illustrates a trajectory of growth in net sales, which surged from 0.00 Cr in March 2016 to 54.73 Cr in March 2019. This growth in total operating income was accompanied by an increase in total expenditure, which rose from 0.00 Cr in March 2016 to 54.33 Cr in March 2019. Operating profit fluctuated, with a peak of 0.80 Cr in March 2018 before dropping to 0.40 Cr in March 2019. The company faced a loss before tax in March 2019, but managed to achieve a profit after tax of 0.04 Cr, marking a recovery from previous losses. The balance sheet reflects a steady increase in total assets and liabilities, with total assets reaching 21.13 Cr in March 2019. Despite these positive trends in sales and assets, the cash flow statements indicate no operational cash flow, highlighting ongoing liquidity challenges for the company.